Кенија - Енглески - Pharmacy and Poisons Board

human albumin 20% - infusion - human albumin 20% - albumin

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

kedrion s.p.a - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where volume deficiency is demonstrated and colloid use is appropriate. kedbumin® is indicated for severe albumin deficiency caused by illness or active bleeding. when albumin deficiency results from excessive protein loss, the effect of albumin administration will be temporary unless the underlying disorder is reversed. kedbumin® is indicated for maintenance of cardiovascular function following the removal of large volumes of ascitic fluid due to cirrhosis [1, 2]. kedbumin® is indicated as a plasma expander in the fluid management of severe forms of ovarian hyperstimulation syndrome (ohss) [3, 4]. kedbumin® is indicated in conjunction with diuretics to correct fluid volume overload associated with ards [5]. kedbumin® is indicated after > 24 hours post burn in patients experiencing severe albumin depletion in order to favor edema re-absorption [6]. kedbumin® is indicated in patients undergoing long term dialysis or for those patients who are fl

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

csl behring ag - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 250 ml - the definitive treatment of major hemorrhage is the transfusion of red blood cells restoring a normal oxygen transport capacity of the blood. since, however, the life-threatening event in major hemorrhage is the loss of blood volume and not the erythrocyte deficit, the blood volume can, as an emergency measure, be supported by alburx® 5, albumin (human) 5% solution or another rapidly acting plasma substitute if blood is not immediately available. this will restore cardiac output and abolish circulatory failure with tissue anoxia. though a four- to fivefold volume of crystalloids may be equally effective, their administration takes more time and creates a general overload with sodium and water. in the presence of dehydration, electrolyte solutions such as ringer's lactate should be administered in conjunction with albumin. apart from damage to the respiratory tract, the development of burn shock is the most life-threatening event in the immediate care of the burned patient. therapy during the first 24 hours i

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

csl behring gmbh - human albumin solution - solution for infusion - 20, 200 gram(s)/litre - albumin

Израел - Енглески - Ministry of Health

takeda israel ltd - albumin human - solution for infusion - albumin human 200 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

Израел - Енглески - Ministry of Health

takeda israel ltd - albumin human - solution for infusion - albumin human 50 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 10 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used.1,2,3 acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. albutein® 20% can be used in such cases.1 albutein 20% may be of value in the treatment of shock or hypotension in renal dialysis patients.1 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid.4,5,6 albutein 20% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics.1,2,7 albutein 20% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when albumin deficit is the result of excessive protein lo

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.05 g in 1 ml - flexbumin 5% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia and cardiopulmonary bypass surgery. flexbumin 5% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 25% albumin should be used.4,6 flexbumin 5% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 5% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 5% is indicated in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace protein loss which accompanies any severe burn.4,6 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass surgery. flexbumin 5% is indicated a

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.20 g in 1 ml - flexbumin 20% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (hdn). flexbumin 20% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% albumin should be used.4,6 flexbumin 20% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 20% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 20% is indicated, in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace the protein loss which accompanies any severe burn.4,6 adult respiratory distress syndrome (ards) flexbumin 20% is indicated, in conjunctio

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used. [1,2,3] acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. albutein 25% can be used in such cases. [1] albutein 25% may be of value in the treatment of shock or hypotension in renal dialysis patients. [1] preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid. [4,5,6] albutein 25% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics. [1,2,7] albutein 25% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when albumin deficit is the result of excessi